Stepping Stones to Success with Drug Treatments for Melanoma
Tags: activated phenotype, clinical research, combinatorial strategies, Contract Research Organizations (CROs), CTLA-4, cytotoxic T cells, Dendritic cell function, Drug treatments for melanoma, helper T cells, immune system, ipilimumab, melanoma specific T cells, metastatic melanoma, pre-clinical research, rafting, surface activation, two-tiered strategyRecently, it was announced that the Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug shown to prolong the lives of patients with advanced skin cancer.
